Table 4.
Treatment options in patients with AKI in liver disease |
---|
Treat associated conditions: • GI bleeding/hypovolemia: fluid resuscitation • Infections: aggressive antibiotics (as per local antibiogram) • Adrenal insufficiency • Avoid nephrotoxic drugs • Treat raised IAP (drain and replace with albumin) • Large volume ascites: paracentesis • Differentiate between natural progression of liver disease with its complications vs. acute AKI with other organ dysfunction • Once in ICU: cardiac output monitoring, fluids, full organ support, prioritize transplant listing • Early vasoconstrictors and albumin |
Pharmacological therapy: • Albumin • Vasoconstrictors including vasopressin and vasopressin analogues, octreotide, norepinephrine • Vaptans (rarely used) |
Assist devices: • Continuous renal replacement therapy ± plasmapheresis • MARS • SPAD • Prometheus |
Surgical therapy • TIPSS ((very rarely done) • Liver transplant |
GI, gastrointestinal; IAP, intra-abdominal pressure; TIPSS, trans-jugular Intrahepatic Porto-systemic shunt; ICU, intensive care unit, MARS, molecular adsorbent recirculation system; SPAD, single pass albumin dialysis